SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-626517
Filing Date
2016-06-20
Accepted
2016-06-20 16:43:00
Documents
2
Group Members
VIVO VENTURES FUND VII, L.P.VIVO VENTURES VII AFFILIATES FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d213594dsc13da.htm SC 13D/A 61766
2 EX-99.1 d213594dex991.htm EX-99.1 4767
  Complete submission text file 0001193125-16-626517.txt   68066
Mailing Address 575 HIGH STREET #201 PALO ALTO CA 94301
Business Address 575 HIGH STREET #201 PALO ALTO CA 94301 (650) 688-0818
VIVO VENTURES VII, LLC (Filed by) CIK: 0001565020 (see all company filings)

IRS No.: 274484686 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Subject) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88586 | Film No.: 161722558
SIC: 2834 Pharmaceutical Preparations